Filtros de búsqueda

Lista de obras de Christian Geisler

15-year follow-up of the Second Nordic Mantle Cell Lymphoma trial (MCL2): prolonged remissions without survival plateau

artículo científico publicado en 2016

Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia

artículo científico publicado en 2011

Autologous transplantation and management of younger patients with mantle cell lymphoma ⬇️

artículo científico publicado el 23 de mayo de 2012

Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study

artículo científico publicado en 2014

Clonal hematopoiesis evolves from pre-treatment clones and stabilizes after end of chemotherapy in patients with MCL

artículo científico publicado en 2020

Combination of two anti-CD5 monoclonal antibodies synergistically induces complement-dependent cytotoxicity of chronic lymphocytic leukaemia cells

artículo científico publicado en 2013

Computerized image analysis of the Ki-67 proliferation index in mantle cell lymphoma

artículo científico publicado en 2014

Frontline low-dose alemtuzumab with fludarabine and cyclophosphamide prolongs progression-free survival in high-risk CLL.

artículo científico publicado en 2014

High dose cytarabine with rituximab is not enough in first-line treatment of mantle cell lymphoma with high proliferation: early closure of the Nordic Lymphoma Group Mantle Cell Lymphoma 5 trial

artículo científico publicado en 2013

Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial

artículo científico publicado en 2014

Lenalidomide-bendamustine-rituximab in patients older than 65 years with untreated mantle cell lymphoma.

artículo científico publicado en 2016

Long-term molecular remissions in patients with indolent lymphoma treated with rituximab as a single agent or in combination with interferon alpha-2a: a randomized phase II study from the Nordic Lymphoma Group

artículo científico publicado en 2008

Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo-purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group

artículo científico publicado en 2008

Mantle cell lymphoma - does primary intensive immunochemotherapy improve overall survival for younger patients?

artículo científico publicado en 2009

Mantle cell lymphoma: are current therapies changing the course of disease?

artículo científico publicado en 2009

MicroRNAs in mantle cell lymphoma

artículo científico

Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC + autologous stem-cell support: still very long survival but late relapses do occur.

artículo científico publicado en 2012

Nordic MCL3 study: 90Y-ibritumomab-tiuxetan added to BEAM/C in non-CR patients before transplant in mantle cell lymphoma

artículo científico publicado en 2014

Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations

artículo científico publicado en 2014

Ofatumumab in poor-prognosis chronic lymphocytic leukemia: a phase IV, non-interventional, observational study from the European Research Initiative on Chronic Lymphocytic Leukemia

artículo científico publicado en 2015

PTK2 expression and immunochemotherapy outcome in chronic lymphocytic leukemia

artículo científico publicado en 2014

Pre-emptive treatment with rituximab of molecular relapse after autologous stem cell transplantation in mantle cell lymphoma.

artículo científico publicado en 2009

Real world data on primary treatment for mantle cell lymphoma: a Nordic Lymphoma Group observational study

artículo científico publicado en 2014

SOX11 and TP53 add prognostic information to MIPI in a homogenously treated cohort of mantle cell lymphoma--a Nordic Lymphoma Group study

artículo científico publicado en 2014

Short telomere length is associated with NOTCH1/SF3B1/TP53 aberrations and poor outcome in newly diagnosed chronic lymphocytic leukemia patients

artículo científico publicado en 2013

Silenced B-cell receptor response to autoantigen in a poor-prognostic subset of chronic lymphocytic leukemia

artículo científico publicado en 2014

Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies

artículo científico publicado en 2012

TP53 mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapy

artículo científico publicado en 2017

The Danish National Chronic Lymphocytic Leukemia Registry

artículo científico publicado en 2016

The Mantle Cell Lymphoma International Prognostic Index (MIPI) is superior to the International Prognostic Index (IPI) in predicting survival following intensive first-line immunochemotherapy and autologous stem cell transplantation (ASCT).

artículo científico publicado en 2009

miR-18b overexpression identifies mantle cell lymphoma patients with poor outcome and improves the MIPI-B prognosticator

artículo científico publicado en 2015

p53 is associated with high-risk and pinpoints TP53 missense mutations in mantle cell lymphoma

artículo científico publicado en 2020

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda